143 related articles for article (PubMed ID: 31522413)
21. Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry.
Macey MG; McCarthy DA; Milne T; Cavenagh JD; Newland AC
Cytometry; 1999 Aug; 38(4):153-60. PubMed ID: 10440853
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometry in the clinical laboratory. Principles, applications and problems.
Ruiz-Arguelles A
Clin Chim Acta; 1992 Oct; 211(3):S13-27. PubMed ID: 1458606
[No Abstract] [Full Text] [Related]
23. Titering antibodies.
Stewart CC; Stewart SJ
Curr Protoc Cytom; 2001 May; Chapter 4():Unit 4.1. PubMed ID: 18770707
[TBL] [Abstract][Full Text] [Related]
24. Quality Control of Immunophenotyping.
Greig B
Methods Mol Biol; 2019; 2032():227-279. PubMed ID: 31522423
[TBL] [Abstract][Full Text] [Related]
25. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology.
Johansson U; Bloxham D; Couzens S; Jesson J; Morilla R; Erber W; Macey M;
Br J Haematol; 2014 May; 165(4):455-88. PubMed ID: 24620735
[No Abstract] [Full Text] [Related]
26. Optimizing a multicolor immunophenotyping assay.
Mahnke YD; Roederer M
Clin Lab Med; 2007 Sep; 27(3):469-85, v. PubMed ID: 17658403
[TBL] [Abstract][Full Text] [Related]
27. Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses.
Pitoiset F; Cassard L; El Soufi K; Boselli L; Grivel J; Roux A; Klatzmann D; Chaput N; Rosenzwajg M
Cytometry A; 2018 Aug; 93(8):793-802. PubMed ID: 30168890
[TBL] [Abstract][Full Text] [Related]
28. Immunological monitoring utilizing novel probes.
Stewart CC; Stewart SJ
Ann N Y Acad Sci; 1993 Mar; 677():94-112. PubMed ID: 8494251
[No Abstract] [Full Text] [Related]
29. HLA-B27 phenotyping with flow cytometry: further improvement by multiple monoclonal antibodies.
Hoffmann JJ; Janssen WC
Clin Chem; 1997 Oct; 43(10):1975-81. PubMed ID: 9342021
[TBL] [Abstract][Full Text] [Related]
30. Detection of intracellular/intranuclear antigens. Applications in leukemia/lymphoma analysis.
Widen RH
Methods Mol Biol; 1998; 91():47-55. PubMed ID: 9664480
[No Abstract] [Full Text] [Related]
31. Immunophenotyping of Acute Myeloid Leukemia.
Galera PK; Jiang C; Braylan R
Methods Mol Biol; 2019; 2032():281-296. PubMed ID: 31522424
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotyping of Live Human Pluripotent Stem Cells by Flow Cytometry.
Riordon DR; Boheler KR
Methods Mol Biol; 2018; 1722():127-149. PubMed ID: 29264803
[TBL] [Abstract][Full Text] [Related]
33. Improved panels for clinical immune phenotyping: Utilization of the violet laser.
Ryherd M; Plassmeyer M; Alexander C; Eugenio I; Kleschenko Y; Badger A; Gupta R; Alpan O; Sønder SU
Cytometry B Clin Cytom; 2018 Sep; 94(5):671-679. PubMed ID: 28493330
[TBL] [Abstract][Full Text] [Related]
34. Cytometric analysis of BAL T cells labeled with a standardized antibody cocktail correlates with immunohistochemical staining.
Smith PA; Kohli LM; Wood KL; Hage CA; Twigg HL; Knox KS
Cytometry B Clin Cytom; 2006 May; 70(3):170-8. PubMed ID: 16568476
[TBL] [Abstract][Full Text] [Related]
35. Standardization of cytokine flow cytometry assays.
Maecker HT; Rinfret A; D'Souza P; Darden J; Roig E; Landry C; Hayes P; Birungi J; Anzala O; Garcia M; Harari A; Frank I; Baydo R; Baker M; Holbrook J; Ottinger J; Lamoreaux L; Epling CL; Sinclair E; Suni MA; Punt K; Calarota S; El-Bahi S; Alter G; Maila H; Kuta E; Cox J; Gray C; Altfeld M; Nougarede N; Boyer J; Tussey L; Tobery T; Bredt B; Roederer M; Koup R; Maino VC; Weinhold K; Pantaleo G; Gilmour J; Horton H; Sekaly RP
BMC Immunol; 2005 Jun; 6():13. PubMed ID: 15978127
[TBL] [Abstract][Full Text] [Related]
36. One-Tube Multicolor Flow Cytometry Assay (OTMA) for Comprehensive Immunophenotyping of Peripheral Blood.
Donaubauer AJ; Rühle PF; Becker I; Fietkau R; Gaipl US; Frey B
Methods Mol Biol; 2019; 1904():189-212. PubMed ID: 30539471
[TBL] [Abstract][Full Text] [Related]
37. Standardisation of flow cytometry for whole blood immunophenotyping of islet transplant and transplant clinical trial recipients.
Jimenez Vera E; Chew YV; Nicholson L; Burns H; Anderson P; Chen HT; Williams L; Keung K; Zanjani NT; Dervish S; Patrick E; Wang XM; Yi S; Hawthorne W; Alexander S; O'Connell PJ; Hu M
PLoS One; 2019; 14(5):e0217163. PubMed ID: 31116766
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotyping of hematopoietic neoplasms.
Chu PG; Chang KL; Arber DA; Weiss LM
Semin Diagn Pathol; 2000 Aug; 17(3):236-56. PubMed ID: 10968709
[TBL] [Abstract][Full Text] [Related]
39. Double-staining artefact observed in certain individuals during dual-colour immunophenotyping of lymphocytes by flow cytometry.
Ekong T; Gompels M; Clark C; Parkin J; Pinching A
Cytometry; 1993; 14(6):679-84. PubMed ID: 8404375
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometry immunophenotyping of hematolymphoid neoplasia.
Calvo KR; McCoy CS; Stetler-Stevenson M
Methods Mol Biol; 2011; 699():295-316. PubMed ID: 21116989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
